Discussions on Diversity: Gender Identity
Among clinical research’s underrepresented groups: transgender and nonbinary people. One study estimates there are 1.6 million transgender people in the U.S. alone and about one-quarter of those people identify as nonbinary1. In the latest U.K. census, 262,000 respondents identified as transgender, including 30,000 nonbinary respondents2. In clinical trials, these communities have been nearly unaccounted for.
Guided by the dual goals of greater understanding and wider inclusion, Parexel set out to investigate the key barriers to gender diversity in clinical research.